- Home
- FURY vs SCNX Comparison
FURY vs SCNX Comparison
Compare FURY & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FURY
- SCNX
- Stock Information
- Founded
- FURY 2008
- SCNX 2010
- Country
- FURY Canada
- SCNX United States
- Employees
- FURY N/A
- SCNX N/A
- Industry
- FURY Precious Metals
- SCNX Other Pharmaceuticals
- Sector
- FURY Basic Materials
- SCNX Health Care
- Exchange
- FURY Nasdaq
- SCNX Nasdaq
- Market Cap
- FURY 59.1M
- SCNX 59.2M
- IPO Year
- FURY N/A
- SCNX 2020
- Fundamental
- Price
- FURY $0.37
- SCNX $8.00
- Analyst Decision
- FURY Strong Buy
- SCNX
- Analyst Count
- FURY 1
- SCNX 0
- Target Price
- FURY $2.00
- SCNX N/A
- AVG Volume (30 Days)
- FURY 86.5K
- SCNX 11.6K
- Earning Date
- FURY 11-12-2024
- SCNX 02-10-2025
- Dividend Yield
- FURY N/A
- SCNX N/A
- EPS Growth
- FURY N/A
- SCNX N/A
- EPS
- FURY N/A
- SCNX 3.55
- Revenue
- FURY N/A
- SCNX N/A
- Revenue This Year
- FURY N/A
- SCNX $1,085.75
- Revenue Next Year
- FURY N/A
- SCNX N/A
- P/E Ratio
- FURY N/A
- SCNX $3.41
- Revenue Growth
- FURY N/A
- SCNX 166.67
- 52 Week Low
- FURY $0.32
- SCNX $3.69
- 52 Week High
- FURY $0.59
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- FURY 39.22
- SCNX N/A
- Support Level
- FURY $0.39
- SCNX N/A
- Resistance Level
- FURY $0.44
- SCNX N/A
- Average True Range (ATR)
- FURY 0.02
- SCNX 0.00
- MACD
- FURY -0.00
- SCNX 0.00
- Stochastic Oscillator
- FURY 0.00
- SCNX 0.00
About FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.